ClinicalTrials.gg
Status unknownNCT06538454Updated Aug 5, 2024

Effects of Resistance Training Intensity on Cardiovascular Parameters of Hypertensive Women

An interventional study of Resistance training in Arterial Hypertension, Postmenopausal; Menorrhagia and Cardiovascular Diseases, sponsored by University of Sao Paulo. Status unknown at 1 site in Brazil. Open to female participants aged 50 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-08-05.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2024), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
50 Years to 65 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to understand about the effects of resistance training (RT) intensity on cardiovascular parameters in postmenopausal women with systemic arterial hypertension (SAH). The main research questions are:

  • Does the intensity of RT impact blood pressure (BP) in postmenopausal women with SAH?
  • How does RT intensity affect heart rate (HR) and their variability (HRV), endothelial function (EF), and nitric oxide (NO) biomarker synthesis in this population?
  • What are the effects of RT intensity on affectivity and rate of perceived exertion (RPE)?

Researchers will compare two different intensities of RT (60% of the load for 1 repetition maximum [1RM] and 80% of 1RM) to determine their effects on the mentioned cardiovascular and perceptual parameters.

Participants will:

In the acute experiment:

  • Perform the same RT session in a crossover design, training with 60% of 1RM in one condition and 80% of 1RM in another condition
  • Have BP, HR, and HRV measured before, immediately after, and for one hour post-session
  • Report affectivity before each session and at the end, along with RPE

In the chronic experiment:

  • Be randomized into two groups: one training with 60% of 1RM and the other with 80% of 1RM
  • Undergo a 10-week intervention period with evaluations before, during, and after the intervention
  • Have BP, HR, affective responses, and RPE measured at multiple time points
  • Have EF, HRV, and salivary concentrations of NO biomarkers assessed before and after the intervention
Read the detailed description

Physical training has been recommended as a non-pharmacological therapeutic strategy that can promote improvements in blood pressure levels in patients with systemic arterial hypertension (SAH). Resistance training (RT) has emerged due to the various benefits it promotes, including reducing blood pressure (BP) in this population, as improvements in heart rate variability (HRV) and endothelial function (EF). Guidelines suggest an intensity between 50% and 80% of 1 repetition maximum (1RM) in RT, reflecting a range of maximum repetitions between 9 and 26. However, there is a lack of studies that have made a direct comparison of the effect of different intensities in cardiovascular parameters of these patients. Therefore, the objective of this study will be to evaluate, acutely and chronically, the effect of RT intensity on BP, heart rate (HR), HRV, endothelial function, salivary concentrations of nitric oxide (NO) biomarker synthesis, also affectivity and rate of perceived exertion (RPE) of postmenopausal women with SAH. The study will be conducted in two stages, with two experiments: one acute and one chronic. In the acute experiment, with a crossover design, participants will perform the same RT session (with the order of these sessions being random), but in one condition they will train with 60% of 1RM and in another with 80% of 1RM. BP, HR and HRV will be measured before, at the end and for one hour after the session (hypotensive effect of the exercise). Affectivity will be measured before each test and at the end together with PSE. In the chronic study, participants will be randomized to one group that will train with 60% of 1RM and another group that will train with 80% of 1RM. Before, during and after the intervention, which will last 10 weeks, participants will be evaluated for BP, HR, affective responses and RPE, with EF, HRV and salivary concentrations of NO biomarkers measured before and after the intervention.

02

Conditions studied

  • Arterial Hypertension
  • Postmenopausal; Menorrhagia
  • Cardiovascular Diseases

Keywords

  • Resistance training
  • Intensity
  • Blood pressure
  • Heart rate variability
  • Endothelial function
03

In context

Hypertension

6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.

This study's planned enrollment of 24 is below the median of 90 across 5,095 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,030 studies on the registry; 92 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women with 50 to 65 old years;
  • Postmenopausal diagnosis (amenorrhea for 12 months or more);
  • Previous diagnosis of hypertension and treat with medications;
  • Physically inactive.

Exclusion criteria

Exclusion Criteria:

  • History of other cardiovascular problems (heart failure, heart attack, stroke, etc);
  • Grade II obesity (BMI ≥ 35 kg/m²);
  • Medications (beta-blockers and/or non-dihydropyridine calcium channel blockers);
  • Systolic blood pressure at rest above 160 mmHg and/or dyastolic blood presure above 105 mmHg;
  • Unable to perform resistance exercise due to musculoskeletal or cognitive reasons.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
24 participants (estimated)

Study arms

  • Active comparator
    80% of 1 repetition maximum

    The recent guideliness suggest a resistance training intensity for this population between 50 and 80% of 1 repetition maximum (1RM), i.e, this group will training in accordance with the recommendations. These group will be training with 80% 1RM, performining 8-10 repetitions per set.

    Behavioral: Resistance training

  • Active comparator
    60% of 1 repetition maximum

    The recent guideliness suggest a resistance training intensity for this population between 50 and 80% of 1 repetition maximum (1RM), i.e, this group will training in accordance with the recommendations. These group will be training with 60% 1RM, performining 18-20 repetitions per set.

    Behavioral: Resistance training

Interventions

  • BehavioralResistance training

    The exercises will be the same in both stages: squat, bench press, stiff, rowing, hip thrust and shoulder press. Futhermore, the rest interval (2 minutes) and the exercise order (alterning upper and lower limbs) also will be the same in the stages. In the chronic experiment, the resistance training will be carried for 10 weeks with 2 weekly sessions in alternate days. The sets in both groups will be carried close to muscle failure. The difference between groups is the intensity, who reflects the repetition zone. The 80%1RM group will be perform 8-10 repetitions per set, while the 60%1RM group will be perform 18-20 repetitions.

    Also known as: Strength training

06

What researchers measure

Primary outcomes

  1. Values of systolic and diastolic blood pressure (mmHg)

    This measurement will be assessed in both stages. In the acute phase, this measurement will be performed on the participant before, after and up to one hour after the end of the training session. In the chronic phase, this measure will be performed in participant after a rest in a quiet room with temperature controlled before (baseline) and after 10 week of intervention. Futhermore, along the intervention these measure will be performed before and after training sessions.

    Time frame: Up to end of study data collection (both stages), i.e, assesed up to 1 year

Secondary outcomes

  1. Values of heart rate variability (ms)

    This measurement will be assessed in both stages. In the acute phase, this measurement will be performed on the participant before, after and up to one hour after the end of the training session. In the chronic phase, this measure will be performed in participant after a rest in a quiet room with temperature controlled before (baseline) and after 10 week of intervention. Futhermore, along the intervention these measure will be performed before and after training sessions.

    Time frame: Up to end of study data collection (both stages), i.e, assesed up to 1 year

  2. Endothelial function (Flow mediated dilatation %)

    This measurement will be performed before acute experiment (baseline) and after 10 week intervention (end of chronic experiment) in a quiet room with controlled temperature.

    Time frame: Up to end of chronic experiment (baseline and post-intervention values), assesed up to 1 year

  3. Salivary concentrations of nitric oxide (mmol/L)

    This measurement will be performed before acute experiment (baseline) and after 10 week intervention (end of chronic experiment).

    Time frame: Up to end of chronic experiment (baseline and post-intervention values), i.e, assesed up to 1 year

  4. Rate of perceived exertion (scale from 1 to 10)

    This measurement will be performed after all training sessions, i.e, in both stages. The participants will be remembered the meanings of the scale.

    Time frame: Up to end of study data collection (both stages), i.e, assesed up to 1 year

  5. Affectivity (scale from -5 to +5)

    This measurement will be performed before and after all training sessions, i.e, in both stages. The participants will be remembered the meanings of the scale.

    Time frame: Up to end of study data collection (both stages), i.e, assesed up to 1 year

07

Study locations

1 of 1 sites recruiting
  • Laboratório de Fisiologia do Exercício e Metabolismo
    Ribeirão Preto, São Paulo, Brazil
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06538454
Responsible party
Leonardo da Silva Gonçalves (Principal Investigator, University of Sao Paulo) — Principal investigator
First posted
Aug 5, 2024
Start date
Jul 23, 2024
Primary completion
Sep 2024 (estimated)
Completion
Sep 2025 (estimated)
Last update
Aug 5, 2024

Study contacts

Leonardo S Gonçalves
Contact
leonardo.edfisica@usp.br
16981806105

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion